search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
138 new news items in the last 24 hours
  1. Home
  2. Medio

The FDA has approved aceclidine eye drops to treat presbyopia, providing a quick and effective solution for adults over 45.

Liviu Brăteanu
whatsapp
facebook
linkedin
x
copy-link copy-link
9 August 2025, 09:00
main event image
Health
Foto: Pixabay
google-preference

Always see our news on Google

The US Food and Drug Administration (FDA) has approved eye drops with 1.44% aceclidine, a world first for treating presbyopia, which affects most adults over 45. These drops contract the pupil, improving near vision without affecting distance vision. Clinical trials have shown that the effect appears within 30 minutes and lasts up to ten hours, with minimal side effects. The drug, called Vizz, will be available in the US from October 2025.

Sources

sursa imagine
Digi24
SUA aprobă primele picături pentru ochi care corectează vederea de aproape la adulți
sursa imagine
News.ro
Primele picături pentru ochi care corectează vederea de aproape, autorizate în SUA
sursa imagine
Ziare.com
Primele picături care corectează vederea de aproape. Soluția care te poate ajuta să renunți la ochelari la bătrânețe

Latest News

23:48

Mark Rutte stated that the Trump-Putin-Xi meeting is “absolutely normal” and is not a cause for concern

23:30

Anthropic closes its stock market debut at $97.17 per share / What this result says about Wall Street’s confidence in artificial intelligence

23:19

Donald Trump intervened by phone at the “Coalition of the Willing” meeting, where he reportedly questioned the continuation of financial and military aid to Kyiv

22:59

Sorin Grindeanu supports expanding the powers of Marian Neacșu, the sole deputy prime minister in the Niculescu Government

22:51

Alexandru Nazare announced the preparation of RoBOOST / The Fund will attract private capital for Romanian companies

See more news

NEWS ON THE SAME TOPICS

event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
Health
The Minister of Health proposes that treatments for multiple sclerosis also be dispensed through community pharmacies, starting in 2027
event image
International
USA: The FDA has authorized the Aletta robot, the first robotic device that collects blood, under the supervision of a specialist.
event image
Economy
Morphosis Capital takes control of Dr. Mrini Ophthalmology Hospital and prepares a nationwide clinic network
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
FDA treatment adults

Editor’s Recommendations

main event image
Economy
Yesterday 21:30

Anthropic closes its stock market debut at $97.17 per share / What this result says about Wall Street’s confidence in artificial intelligence

main event image
Politics
Yesterday 18:00

Nicușor Dan, about Marian Neacșu: “A professional”

Sources
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
Yesterday 14:47

EXCLUSIVE Ranking of companies in relevant online sources in Romania: Nvidia dominates company visibility. Finance and investments lead the economic agenda

main event image
Opinions
Yesterday 08:52

Andrei Pleșu: What Our Ministers Were and What They Have Become

main event image
Exclusive
Yesterday 08:14

EXCLUSIVE The top domestic political topics trending over the past week / The Lyrica shortage crisis, Marian Neacșu’s new responsibilities, and debates over administrative reform

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol